Responses to Biological therapy in severe eosinophilic asthma
Alvarez-Puebla, MJ; Arroabarren, E; Zavala, MJ; Corcuera, A; Olaguibel, A; Olaguibel, JM.
J. investig. allergol. clin. immunol
; 29(4): 335-337, 2019. graf
Artículo en Inglés | IBECS (España) | ID: ibc-188768
Documentos relacionados
[Concept of remission in severe asthma].
Review of monoclonal antibody therapies in asthma and allergic diseases - a new paradigm for precision medicine.
Narrative review to capture patients' perceptions and opinions about non-response and response to biological therapy for severe asthma.
Clinical remission with biologic therapies in severe asthma: a matter of definition.
[Effectiveness and safety of biological therapy in patients with severe asthma in a real clinical practice].
Precision medicine for severe asthma - Biological targeted therapy.
Clinical remission with biologic therapies in severe asthma: a matter of definition.
Transition of Adolescents With Severe Asthma From Pediatric to Adult Care in Spain: The STAR Consensus.
Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies.
Biological therapies for eosinophilic asthma.